Block Lisa M, Hartmann Emily C, King Jason, Chakmakchy Saygin, King Timothy, Bentz Michael L
Division of Plastic & Reconstructive Surgery, University of Wisconsin.
Plast Reconstr Surg Glob Open. 2019 Jan 15;7(1):e2015. doi: 10.1097/GOX.0000000000002015. eCollection 2019 Jan.
Defects resulting from gynecologic oncology resections can range from small external defects to total exenterations, requiring complex pelvic reconstruction. We aim to investigate the patient and surgical factors that influence complication rates, reoperation rates, and length of stay. We hypothesize that this patient cohort will have high complication and reoperation rates that are likely most affected by their medical and extirpative surgery factors, with less direct impact from their reconstructive surgery procedures.
All cases of reconstruction following resection of a gynecological oncology tumor at the University of Wisconsin Hospital over the last 14 years were reviewed. Forty-three patients were identified who required 66 flaps for reconstruction.
Mean follow-up period was 19 months. Overall complication rate was 65% and reoperation rate was 33%. Plastic surgery flap-specific complication and reoperation rates were 47% and 19%, respectively, and were not significantly associated with any patient risk factors. Flap reconstruction subtype was not associated with time to complete healing, complication rate, or reoperation. Prior chemotherapy was significantly correlated with increased rate of overall complication ( = 0.0253) and reoperation ( = 0.0448), but prior radiation was not. Mean hospital stay was 11 days (SD ± 9 d). Factors found to be significantly associated with an increase in hospitalization length were increasing number of comorbidities ( = 0.021), exenteration defects ( = 0.0122), myocutaneous flap reconstruction ( = 0.0003), radiation ( = 0.0004), and chemotherapy = 0.0035).
This patient cohort has an overall high complication and reoperation rate; however, increasingly complex reconstruction is not associated with significant differences in complication rates or reoperation.
妇科肿瘤切除造成的缺损范围从小的体表缺损到全盆腔脏器切除术,需要复杂的盆腔重建。我们旨在研究影响并发症发生率、再次手术率和住院时间的患者因素和手术因素。我们假设该患者群体并发症和再次手术率较高,可能主要受其内科和根治性手术因素影响,而重建手术操作的直接影响较小。
回顾了威斯康星大学医院过去14年中所有妇科肿瘤切除术后重建的病例。确定了43例需要66块皮瓣进行重建的患者。
平均随访期为19个月。总体并发症发生率为65%,再次手术率为33%。整形外科皮瓣特异性并发症和再次手术率分别为47%和19%,与任何患者风险因素均无显著相关性。皮瓣重建亚型与完全愈合时间、并发症发生率或再次手术无关。既往化疗与总体并发症发生率(P = 0.0253)和再次手术率(P = 0.0448)的增加显著相关,但既往放疗则不然。平均住院时间为11天(标准差±9天)。发现与住院时间增加显著相关的因素包括合并症数量增加(P = 0.021)、全盆腔脏器切除缺损(P = 0.0122)、肌皮瓣重建(P = 0.0003)、放疗(P = 0.0004)和化疗(P = 0.0035)。
该患者群体总体并发症和再次手术率较高;然而,日益复杂的重建与并发症发生率或再次手术的显著差异无关。